NSE - Delayed Quote INR

Piramal Pharma Limited (PPLPHARMA.NS)

Compare
215.11 -12.99 (-5.69%)
At close: 3:30 PM GMT+5:30

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Ms. Nandini Ajay Piramal Executive Chairperson -- -- 1980
Mr. Vivek Valsaraj President, CFO & Executive Whole-Time Director -- -- 1973
Ms. Tanya Sanish Company Secretary & Compliance Officer -- -- --
Mr. Peter Daniel DeYoung CEO of Piramal Global Pharma & Director -- -- 1978
Vinay Agarwal Senior Vice President of Operations -- -- 1964
Mr. Gagan Borana Head of Investor Relations & Sustainability -- -- --
Sameer Penkar Vice President of Marketing -- -- --
Prashanth M. S. Vice President of Sales -- -- 1973
Mr. Vikram Duggal Senior Vice President of Human Resources -- -- 1975
Mr. Debashish Chakravorty Executive Vice President of India & UK Formulations -- -- 1967

Piramal Pharma Limited

Piramal Ananta
Ground Floor Agastya Corp Park, Opp. Fire Brigade Kamani Junction, LBS Marg, Kurla West
Mumbai, 400 070
India
91 22 3802 3000 https://www.piramalpharma.com
Sector:?
Healthcare
Full Time Employees:?
6,719

Description

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.

Corporate Governance

Piramal Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

July 12, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers